A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...

A 24-year-old Watchung woman already in trouble for allegations of bias intimidation is accused of stalking and threatening a ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Merck & Company (MRK – Research Report), ...

The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

Tuesday looks fine, although mostly cloudy and somewhat humid. Wednesday will be a "carry the umbrella" kind of day for New ...

Reviewed by David KindnessReviewed by David Kindness Pfizer Inc. (PFE) is a leading global biopharmaceutical company based in ...

A heated controversy over vulgar political signs along a busy road in Franklin Township, Somerset County, has come to a fiery ...

Just hours after it began, legal betting on the outcome of U.S. Congressional elections has been put on hold by a federal ...